Clinical Trial

Support Pathway for ENT Cancer Patients in a Support Care Day Hospital

Study acronym: PAKO-HDJ
Recruiting
View on ClinicalTrials.gov →
Summary
Cancers of the upper respiratory / digestive tract are a major public health problem, ranking 5th among the most common cancers. Surgery plays a central role in the recommended treatments for this type of pathology. The surgical procedure and its after-effects can be anxiety-provoking and have a major psychological, physical and social impact on patients over the long term. Our institution's standard protocol is based on a pre-operative supportive care day hospital. The aim of this study is to compare our current care pathway with a more extensive interdisciplinary care pathway focused on patients' needs, in order to reduce anxiety and improve the quality of life of patients undergoing surgery for cancers of the upper respiratory / digestive tract. Our aim is to use a prospective single-centre interventional study to assess the impact of adding three post-operative day hospitals to the existing care pathway in terms of reducing anxiety and improving the quality of life of patients undergoing surgery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-16; most recent amendment 2026-03-31.
Status change: Not Yet Recruiting → Recruiting 2024-10-08
Trial Details
NCT Number NCT06512662
Lead Sponsor Clinique Pasteur Lanroze
Conditions Otorhinolaryngologic Neoplasms
Enrollment 60 participants
Start Date 2024-10-08
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-06